News list
February 7, 2025 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2025 Summary of Consolidated Results |
February 7, 2025 |
Investor Relations |
Notice of Revision of Consolidated Earnings Forecast for the Fiscal Year Ending March 31, 2025. |
November 7, 2023 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2024 Summary of Consolidated Results |
November 7, 2023 |
Investor Relations |
|
August 7, 2023 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2024 Summary of Consolidated Results |
July 14, 2023 |
Other |
Notice of Changing Subsidiary's Indirectly Owned Subsidiary |
June 5, 2023 |
Investor Relations |
Notice of the 58th Ordinary General Meeting of Shareholders |
May 12, 2023 |
Investor Relations |
Financial Results for the FYE March 2023 Summary of Consolidated Results |
May 12, 2023 |
Investor Relations |
|
May 12, 2023 |
Human Resources |
Notice Regarding: Transfer of President and Representative Director and Directors |
February 7, 2023 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2023 Summary of Consolidated Results |
November 4, 2022 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2023 Summary of Consolidated Results |
November 4, 2022 |
Investor Relations |
|
August 5, 2022 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2023 Summary of Consolidated Results |
June 29, 2022 |
Other |
|
June 3, 2022 |
Investor Relations |
NOTICE OF THE 57TH ORDINARY GENERAL MEETING OF SHAREHOLDERS |
May 12, 2022 |
Investor Relations |
Financial Results for the FYE March 2022 Summary of Consolidated Results |
April 15, 2022 |
Product |
|
February 8, 2022 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2022 Summary of Consolidated Results |
November 5, 2021 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2022 Summary of Consolidated Results |
September 17, 2021 |
Other |
Announce the formation of a business alliance with Fresenius Medical Care |
August 6, 2021 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2022 Summary of Consolidated Results |
July 30, 2021 |
Other |
Renewal of our website |
May 12, 2021 |
Investor Relations |
Financial Results for the FYE March 2021 Summary of Consolidated Results |
February 6, 2021 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2021 Summary of Consolidated Results |
November 6, 2020 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2021 Summary of Consolidated Results |
August 7, 2020 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2021 Summary of Consolidated Results |
June 22, 2020 |
Investor Relations |
Announcement of JMS Group Mid-term Management Plan (April 2020-March 2023) JMS Group Mid-term Management Plan |
May 28, 2020 |
Investor Relations |
Financial Results for the FYE March 2020 Summary of Consolidated Results |
February 6, 2020 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2020 Summary of Consolidated Results |
November 11, 2019 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2020 Summary of Consolidated Results |
August 7, 2019 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2020 Summary of Consolidated Results |
May 17, 2019 |
Investor Relations |
Financial Results for the FYE March 2019 Summary of Consolidated Results |
February 7, 2019 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2019 Summary of Consolidated Results |
November 8, 2018 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2019 Summary of Consolidated Results |
August 8, 2018 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2019 Summary of Consolidated Results |
May 18, 2018 |
Investor Relations |
Financial Results for the FYE March 2018 Summary of Consolidated Results |
May 18, 2018 |
Other |
Notice Regarding: Transfer of Standing Audit & Supervisory Board Member |
March 7, 2018 |
Other |
Notice Regarding Establishment of Joint Venture Companyr |
February 8, 2018 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2018 Summary of Consolidated Results |
November 9, 2017 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2018 Summary of Consolidated Results |
September 19, 2017 |
Investor Relations |
Announcement of JMS Group Mid-term Management Plan (April 2017-March 2020) |
August 9, 2017 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2018 Summary of Consolidated Results |
May 12, 2017 |
Investor Relations |
Financial Results for the FYE March 2017 Summary of Consolidated Results |
February 10, 2017 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2017 Summary of Consolidated Results |
November 10, 2016 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2017 Summary of Consolidated Results |
August 5, 2016 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2017 Summary of Consolidated Results |
May 13, 2016 |
Investor Relations |
Financial Results for the FYE March 2016 Summary of Consolidated Results |
February 5, 2016 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2016 Summary of Consolidated Results |
November 6, 2015 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2016 Summary of Consolidated Results |
August 7, 2015 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2016 Summary of Consolidated Results |
May 8, 2015 |
Investor Relations |
Financial Results for the FYE March 2015 Summary of Consolidated Results |
February 5, 2015 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2015 Summary of Consolidated Results |
November 6, 2014 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2015 Summary of Consolidated Results |
August 7, 2014 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2015 Summary of Consolidated Results |
Jun 2, 2014 |
Investor Relations |
|
May 8, 2014 |
Investor Relations |
Financial Results for the FYE March 2014 Summary of Consolidated Results |
April 7, 2014 |
Investor Relations |
Business alliance in the field of hemodiafiltration |
February 5, 2014 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2014 Summary of Consolidated Results |
December 19, 2013 |
Investor Relations |
Patent and Know-How License Agreement with Huaren Pharmaceutical Co., Ltd. |
November 22, 2013 |
Other |
Our English website has been renewed. |
November 6, 2013 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2014 Summary of Consolidated Results |
August 7, 2013 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2014 Summary of Consolidated Results |
May 9, 2013 |
Investor Relations |
Financial Results for the FYE March 2013 Summary of Consolidated Results |
February 6, 2013 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2013 Summary of Consolidated Results |
November 6, 2012 |
Investor Relations |
Financial Results for the 2nd Quarter of FYE March 2013 Summary of Consolidated Results |
August 7, 2012 |
Investor Relations |
Financial Results for the 1st Quarter of FYE March 2013 |
June 26, 2012 |
Other |
Notice regarding Executive Change |
May 10, 2012 |
Investor Relations |
Financial Results for the FYE March 2012 Summary of Consolidated Results |
February 3, 2012 |
Investor Relations |
Financial Results for the 3rd Quarter of FYE March 2012 |
Company
Human Resources
Hiring
Products
Investor Relations
Sustainability
Other